soreness in the arm; This is a spontaneous report from a Pfizer-sponsored program. A non-contactable consumer (patient) reported that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 27Jan2021 at a  single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had a very tiny soreness in the arm in Jan2021 and its already gone. The patient recovered from the event in Jan2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.